Ciltacabtagene autoleucel achieved a 100% complete response rate in patients with high-risk smoldering multiple myeloma, as ...

The researchers were able to recreate a complete structure that includes the three key cell types in the pancreas, ...

Once destroyed, the immune system is then rebuilt using blood and bone marrow stem cells which would have been collected from the patient’s own blood prior to chemotherapy. The regenerating immune ...

A Des Moines attorney is facing a possible suspension of her law license for repeatedly missing deadlines in her clients’ ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced longer-term data for CASGEVY™ (exagamglogene autotemcel) from global clinical trial ...

Scientists and physicians with City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S., whose Los Angeles comprehensive cancer center is ranked ...

The findings hold ... New Drug Tested to Reduce Side Effect of 'Half-Matched' Stem Cell Transplants Dec. 5, 2024 — Stem cell transplantation is used to treat several types of blood cancers ...

Cathie Wood says a "cure" can generate up to 20x more value than traditional drugs, which appears to explain why two of her firm's funds snapped up shares of the Casgevy co-developer until this past ...

Introduction: Autologous peripheral blood stem cell (PBSC) transplantation has become a standard treatment option for certain hematological malignancies. The collection of PBSCs for transplantation is ...

Researchers report significant progress toward expanding the therapeutic options available for people with non-cancerous blood conditions in five studies presented during the 66th American Society of ...

H3 demethylation that modulates MKP-1/MAPK signaling may account for the long-term inhibitory effect of prenatal dexamethasone exposure on osteoprogenitor proliferation and the consequent ...